search
FDA
Trends
- 1E. coli outbreak tied to raw milk cheese sickens 13 across US▼E. coli outbreak linked to raw milk cheese leads to 13 illnesses and eight hospitalizations across the US: FDA
US health regulators are investigating an E. coli outbreak linked to raw milk cheese that has caused 13 illnesses and eight hospitalizations across the country, according to the FDA. The announcement has raised renewed concerns about the safety of unpasteurized dairy products, with coverage highlighting the risks of raw milk consumption and calls for consumers to check products they may have purchased.
- 2FDA links Ecuadorian black clams to hepatitis A outbreak●FDA warns black clams from Ecuador tied to hepatitis A outbreak, 30 hospitalized
The FDA has issued a warning that black clams imported from Ecuador are linked to a hepatitis A outbreak in the United States, with 30 people hospitalized so far. Consumers are being urged to avoid the shellfish as health officials investigate the source of contamination and track additional cases connected to the product.
- 3Raw milk cheese recalled over E. coli outbreak▼Raw milk cheese recalled over E. coli outbreak, FDA says
US health regulators have announced a recall of raw milk cheese linked to an ongoing E. coli outbreak, according to the FDA. Outlets including DC News Now, WTNH and NewsNation are reporting the recall, which affects consumers who may have purchased the contaminated cheese. Officials typically urge anyone with the product to discard it and seek medical care if symptoms of E. coli infection develop.
- 4Thyroid Medicine Recall Classified as FDA's Highest Risk●Thyroid medicine recall classified under FDA's highest risk level https:// blog.taursnd.haus/display/1a04 1b09-206a-b7ca
A thyroid medicine has been recalled and the recall has been classified under the FDA's most serious risk level, meaning the agency considers the product potentially capable of causing serious harm or death. The news is circulating among readers discussing medication safety and whether patients taking thyroid medication need to check their supply or consult a doctor.
- 5
Disc Medicine is facing investor investigations following an FDA letter related to one of its drug programs. Law firms have announced probes into whether the biotech company misled shareholders about regulatory prospects. The news has drawn attention from biotech investors watching how the FDA's response could affect the company's clinical development plans and share value.
- 6Arrowhead Pharmaceuticals Stock Nears Five-Year High on Phase 3 Win▼ARWR Stock On Track To Hit Over 5-Year Highs – Retail Cheers Phase 3 Breakthrough As Arrowhead Targets Broader FDA Approval
Arrowhead Pharmaceuticals shares are on track to reach their highest level in more than five years after positive Phase 3 trial results, with retail investors celebrating the biotech's momentum. The company is reportedly aiming for a broader FDA approval than initially expected, fueling optimism about the commercial potential of its drug pipeline and driving renewed interest in the stock.